Upregulation of EMMPRIN after permanent focal cerebral ischemia

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1086-1091

  Zhu, Wei ^a,b   Khachi, Steve ^a   Hao, Qi ^a   Shen, Fanxia ^a   Young, William L ^a   Yang, Guo Yuan ^a   Chen, Yongmei ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

EMMPRIN; MMP 9; Stroke

Indexed keywords

CD147 ANTIGEN; GELATINASE B; NEURON SPECIFIC NUCLEAR PROTEIN; VON WILLEBRAND FACTOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; ENDOTHELIUM CELL; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD147; ASTROCYTES; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 9; MICE; PLATELET MEMBRANE GLYCOPROTEINS; UP-REGULATION;

MUS;

EID: 40949097405     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.11.005     Document Type: Article

References (26)

1. Bordador L.C., Li X., Toole B., Chen B., Regezi J., Zardi L., Hu Y., and Ramos D.M. Expression of emmprin by oral squamous cell carcinoma. Int. J. Cancer 85 (2000) 347-352
2. Burggraf D., Liebetrau M., Martens H.K., Wunderlich N., Jager G., Dichgans M., and Hamann G.F. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. Eur. J. Neurosci. 22 (2005) 273-277
3. Caudroy S., Polette M., Nawrocki-Raby B., Cao J., Toole B.P., Zucker S., and Birembaut P. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin. Exp. Metastasis 19 (2002) 697-702
4. Chen Y., Fan Y., Poon K.Y., Achrol A.S., Lawton M.T., Zhu Y., McCulloch C.E., Hashimoto T., Lee C., Barbaro N.M., Bollen A.W., Yang G.Y., and Young W.L. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci. 11 (2006) 3121-3128
5. Chen Y., Pawlikowska L., Yao J.S., Shen F., Zhai W., Achrol A.S., Lawton M.T., Kwok P.Y., Yang G.Y., and Young W.L. Interleukin-6 involvement in brain arteriovenous malformations. Ann. Neurol. 59 (2006) 72-80
6. Davidson B., Konstantinovsky S., Nielsen S., Dong H.P., Berner A., Vyberg M., and Reich R. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin. Cancer Res. 10 (2004) 7335-7346
7. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., and Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res. 842 (1999) 92-100
8. Gabison E.E., Hoang-Xuan T., Mauviel A., and Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87 (2005) 361-368
9. Gursoy-Ozdemir Y., Qiu J., Matsuoka N., Bolay H., Bermpohl D., Jin H., Wang X., Rosenberg G.A., Lo E.H., and Moskowitz M.A. Cortical spreading depression activates and upregulates MMP-9. J. Clin. Invest. 113 (2004) 1447-1455
10. Gwinn W.M., Damsker J.M., Falahati R., Okwumabua I., Kelly-Welch A., Keegan A.D., Vanpouille C., Lee J.J., Dent L.A., Leitenberg D., Bukrinsky M.I., and Constant S.L. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol. 177 (2006) 4870-4879
11. Haug C., Lenz C., Diaz F., and Bachem M.G. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase inducer (EMMPRIN) release by coronary smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1823-1829
12. Lee C., Yang G.Y., Liu W., Guglielmo B.J., Lin E., and Young W.L. Doxycycline and minocycline inhibit cerebral MMP-9 in a dose-dependent manner. Anesth. Analg. 100 (2005) S247 (abstract)
13. Machado L.S., Kozak A., Ergul A., Hess D.C., Borlongan C.V., and Fagan S.C. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 7 (2006) 56
14. Menashi S., Serova M., Ma L., Vignot S., Mourah S., and Calvo F. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res. 63 (2003) 7575-7580
15. Rosell A., Ortega-Aznar A., Alvarez-Sabin J., Fernandez-Cadenas I., Ribo M., Molina C.A., Lo E.H., and Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37 (2006) 1399-1406
16. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
17. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893 (2001) 104-112
18. Sameshima T., Nabeshima K., Toole B.P., Yokogami K., Okada Y., Goya T., Koono M., and Wakisaka S. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int. J. Cancer 88 (2000) 21-27
19. Schmidt R., Bultmann A., Ungerer M., Joghetaei N., Bulbul O., Thieme S., Chavakis T., Toole B.P., Gawaz M., Schomig A., and May A.E. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation 113 (2006) 834-841
20. Seulberger H., Lottspeich F., and Risau W. The inducible blood-brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J. 9 (1990) 2151-2158
21. Shen F., Su H., Fan Y., Chen Y., Zhu Y., Liu W., Young W.L., and Yang G.Y. Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 37 (2006) 2601-2606
22. Tang Y., Nakada M.T., Rafferty P., Laraio J., McCabe F.L., Millar H., Cunningham M., Snyder L.A., Bugelski P., and Yan L. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol. Cancer Res. 4 (2006) 371-377
23. Toole B.P. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr. Top. Dev. Biol. 54 (2003) 371-389
24. Zhang J., Ge H., Wang C., Guo T.B., He Q., Shao Q., and Fan Y. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells. Int. J. Cardiol. (2006)
25. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445
26. Zhu P., Lu N., Shi Z.G., Zhou J., Wu Z.B., Yang Y., Ding J., and Chen Z.N. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis Res. Ther. 8 (2006) R44